| Ident. | Authors (with country if any) | Title |
|---|
| 000125 (2013) |
K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse] | Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study |
| 000126 (2013) |
Marjolein A. Van Der Marck [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; George F. Borm [Pays-Bas] ; Sebastiaan Overeem [Pays-Bas] ; Marten Munneke [Pays-Bas] ; Mark Guttman [Canada] | Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial |
| 000145 (2013) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Alain Destée [France] ; Nobutaka Hattori [Japon] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Werner Poewe [Autriche] ; Mark Stacy [États-Unis] ; Eduardo Tolosa [Espagne] ; Haitao Gao [États-Unis] ; Jennifer Nagel [Suisse] ; Martin Merschhemke [Suisse] ; Ana Graf [Suisse] ; Christopher Kenney [États-Unis] ; Claudia Trenkwalder [Allemagne] | AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study |
| 000148 (2013) |
| A randomized, double‐blind, placebo‐controlled trial of pridopidine in Huntington's disease |
| 000149 (2013) |
D. William Molloy [Irlande (pays)] ; T. I. Standish [Canada] ; Q. Zhou [Canada] ; G. Guyatt [Canada] | A multicenter, blinded, randomized, factorial controlled trial of doxycycline and rifampin for treatment of Alzheimer's disease: the DARAD trial |
| 000162 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study |
| 000321 (2012) |
Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Nègre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarié [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France] | A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease |
| 000323 (2012) |
Roger Kurlan [États-Unis] ; Giovanna Crespi [États-Unis] ; Barbara Coffey [États-Unis] ; Kirsten Mueller-Vahl [Allemagne] ; Stephen Koval [États-Unis] ; Glen Wunderlich [Canada] | A multicenter randomized placebo‐controlled clinical trial of pramipexole for Tourette's syndrome |
| 000326 (2012) |
Jo Watson [Canada] ; Ellen Hodnett ; B. Anthony Armson ; Barbara Davies ; Judy Watt-Watson | A Randomized Controlled Trial of the Effect of Intrapartum Intravenous Fluid Management on Breastfed Newborn Weight Loss |
| 000398 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 000478 (2011) |
Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Iiona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Thérèse Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse] | AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trials |
| 000570 (2010) |
Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis] | Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease |
| 000657 (2010) |
Elisa I. Glover [Canada] ; Joan Martin [Canada] ; Amy Maher [Canada] ; Rebecca E. Thornhill [Canada] ; Gerald R. Moran [Canada] ; Mark A. Tarnopolsky [Canada] | A randomized trial of coenzyme Q10 in mitochondrial disorders |
| 000824 (2009) |
Peter J. Trainer [Royaume-Uni] ; Shereen Ezzat [Canada] ; Gwyn A. D Ouza [Royaume-Uni] ; Gary Layton [Royaume-Uni] ; Christian J. Strasburger [Allemagne] | A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long‐acting octreotide in patients with acromegaly |
| 000958 (2008) |
Richard L. Page [États-Unis] ; Edward L. C. Pritchett [États-Unis] ; Stuart Connolly [Canada] ; William E. Wilkinson [États-Unis] | Azimilide for the Treatment of Atrial Fibrillation, Atrial Flutter, and Paroxysmal Supraventricular Tachycardia: Results of a Randomized Trial and Insights on the Concordance of Symptoms and Recurrent Arrhythmias |
| 000965 (2008) |
Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis] | Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) |
| 000966 (2008) |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000A05 (2007) |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000A40 (2007) |
Dan A. Mendonça [Canada] ; Krishe Menezes [Canada] ; Mandar S. Jog [Canada] | Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial |
| 000B02 (2007) |
David Constantinescu [États-Unis] ; David Mcdermott [États-Unis] ; David Dicenzo [États-Unis] ; Elisabet A. De Blieck [États-Unis] ; Elisabet A. Hyson [Canada] ; Elisabet A. Beal [États-Unis] ; Elisabet A. Bednarczyk [États-Unis] ; Elisabet A. Bogdanov [États-Unis] ; Elisabet A. Metakis [États-Unis] ; Elisabet A. Browne [États-Unis] ; Elisabet A. Lorenzo [États-Unis] ; Elisabet A. Ravina [États-Unis] ; Elisabet A. Kieburtz [États-Unis] | A Randomized Study of the Bioavailability of Different Formulations of Coenzyme Q10 (Ubiquinone) |
| 000B24 (2006) |
Jing-Quan Zhong [République populaire de Chine, Canada] ; Paul Dorian [Canada] ; Wei Zhang [République populaire de Chine] ; Li Li [République populaire de Chine] ; Yun Zhang [République populaire de Chine] | Using Transthoracic Two‐Dimensional Echocardiography to Guide the Placement of Coronary Sinus Catheters: A Randomized Study |
